The Biotech Growth Trust PLC
(the “Company”)
Result of General Meeting
27 January 2020
Following a General Meeting of the Company held today, the Board is pleased to
announce that the resolution put to Shareholders was passed on a show of
hands.
The proxy voting figures are shown below:
Resolution Votes For % Votes Against % Total Votes Cast Votes Withheld
Special Resolution
1. THAT the Company be and is hereby generally and unconditionally authorised in accordance with section 701 of the Companies Act 2006 (the “Act”) to make one or more market purchases (within the meaning of section 693 (4) of the Act) of ordinary shares of 25 pence each in the capital of the Company either for retention as treasury shares for future reissue, resale, transfer or for cancellation. 15,560,677 99.96% 5,972 0.04% 15,566,649 831
Notes:
Any proxy votes which are at the discretion of the Chairman have been included
in the "for" total. A vote withheld is not a vote in law and is not counted in
the votes for or against a resolution.
At the date and time of the General Meeting the total number of Ordinary
shares of 25p each in issue and the total number of voting rights was
40,878,780.
The proxy voting figures will shortly also be available on the Company's
website at http://www.biotechgt.com/
The full text of the resolution can be found in the Notice of General Meeting
contained in the Circular dated 10 January 2020 (the “Circular”), which is
available for viewing at the National Storage Mechanism which can be located
at http://www.morningstar.co.uk/uk/NSM and on the Company’s website,
http://www.biotechgt.com/
In accordance with Listing Rule 9.6.2, the full text of the special business
resolution passed has been submitted to the National Storage Mechanism and
will shortly be available for inspection at:
http://www.morningstar.co.uk/uk/nsm. The special business resolution will
additionally be filed with Companies House.
Capitalised terms used in this announcement shall, unless the context
otherwise requires, bear the meanings given to them in the Circular.
Disclaimer: Neither the contents of the Company's website nor the contents of
any website accessible from hyperlinks on the Company's website (or any other
website) is incorporated into, or forms part of, this announcement.
Legal Entity Identifier: 549300Z41EP32MI2DN29
Enquiries:
Mark Pope
Frostrow Capital LLP
Company Secretary
Telephone: 0203 008 4913
Copyright (c) 2020 PR Newswire Association,LLC. All Rights Reserved